Shuqi Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shuqi Huang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Guoping Yang
Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Qi Pei
Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Qihan Xu
Xiangya School of Pharmaceutical Sciences, Central South University Changsha China
2 shared publications - Junjie Ding
Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine Mahidol University Bangkok Thailand
1 shared publication - Shengnan Zhang
Department of Pharmacy The Third Xiangya Hospital, Central South University Changsha China
1 shared publication Yujie Wen
Department of Pharmacy The Third Xiangya Hospital, Central South University Changsha China
1 shared publication
Latest Publications
- 10 November 2026
- Published by Wiley in Clinical Pharmacology & Therapeutics
Comparing Machine Learning and Population Pharmacokinetic Approaches for Drug Concentration Prediction in Dense and Sparse Data Settings
Population pharmacokinetic (PopPK) models, the gold standard for drug concentration prediction, are relatively complex and time‐consuming; machine learning (ML) excels with high‐dimensional data but remains exploratory. This study systematically evaluated seven ML algorithms—Extreme Gradient Boosting (XGBoost), Long Short‐Term Memory (LSTM), Bidirectional Long Short‐Term Memory (BiLSTM), Gated Recurrent Unit with Decay (GRUD), Phased Long Short‐Term Memory (PLSTM), Neural Controlled Differential Equations (NCDE), and Neural Ordinary Differential Equation (NODE)—and their heterogeneous XGBoost‐based ensembles against PopPK across three data settings: dense phase I trial data; simulated dense data: linear absorption and elimination (LL), Michaelis–Menten absorption with linear elimination (MMA), linear absorption with Michaelis–Menten elimination (MME); and sparse therapeutic drug‐monitoring (TDM) data. On two dense trial data, BiLSTM showed low systematic bias (F30 = 48.44%, MdPE = −6.86%; F30 = 50.62%, MdPE = 1.08%), whereas NCDE (F30 = 50.00%, MdPE = −19.39%) and NODE (F30 = 62.96%, MdPE = 11.77%) achieved the highest F30 values, respectively, compared with PopPK (F30 = 37.50%, MdPE = 24.73%; F30 = 61.73%, MdPE = 14.88%). BiLSTM showed robust extrapolation across LL, MMA, and MME datasets (F30 ≥ 75%, |MdPE| ≤ 10%). XGBoost lacked extrapolation ability, limiting ensemble gains. On sparse single‐point prior data, XGBoost (F30 = 23.61%, MdPE = −8.42%) was most robust, while PopPK failed to converge. On multi‐point sparse prior data, XGBoost (F30 = 26.84%, MdPE = −5.88%) outperformed PopPK (F30 = 23.63%, MdPE = −13.88%). In single‐point sparse posterior prediction, PopPK (F30 = 29.71%, MdPE = 2.32%) performed best, while several ensembles improved over their neural network components. Overall, BiLSTM showed strong performance in dense data, XGBoost performed best in the prior sparse scenarios, and PopPK retained the advantage after prior concentration information was incorporated. ML approaches achieved similar accuracy to PopPK with unique advantages, representing promising tools for drug concentration prediction.
- 10 November 2026
- Published by Wiley in Clinical Pharmacology & Therapeutics
Comparing Machine Learning and Population Pharmacokinetic Approaches for Drug Concentration Prediction in Dense and Sparse Data Settings
Population pharmacokinetic (PopPK) models, the gold standard for drug concentration prediction, are relatively complex and time‐consuming; machine learning (ML) excels with high‐dimensional data but remains exploratory. This study systematically evaluated seven ML algorithms—Extreme Gradient Boosting (XGBoost), Long Short‐Term Memory (LSTM), Bidirectional Long Short‐Term Memory (BiLSTM), Gated Recurrent Unit with Decay (GRUD), Phased Long Short‐Term Memory (PLSTM), Neural Controlled Differential Equations (NCDE), and Neural Ordinary Differential Equation (NODE)—and their heterogeneous XGBoost‐based ensembles against PopPK across three data settings: dense phase I trial data; simulated dense data: linear absorption and elimination (LL), Michaelis–Menten absorption with linear elimination (MMA), linear absorption with Michaelis–Menten elimination (MME); and sparse therapeutic drug‐monitoring (TDM) data. On two dense trial data, BiLSTM showed low systematic bias (F30 = 48.44%, MdPE = −6.86%; F30 = 50.62%, MdPE = 1.08%), whereas NCDE (F30 = 50.00%, MdPE = −19.39%) and NODE (F30 = 62.96%, MdPE = 11.77%) achieved the highest F30 values, respectively, compared with PopPK (F30 = 37.50%, MdPE = 24.73%; F30 = 61.73%, MdPE = 14.88%). BiLSTM showed robust extrapolation across LL, MMA, and MME datasets (F30 ≥ 75%, |MdPE| ≤ 10%). XGBoost lacked extrapolation ability, limiting ensemble gains. On sparse single‐point prior data, XGBoost (F30 = 23.61%, MdPE = −8.42%) was most robust, while PopPK failed to converge. On multi‐point sparse prior data, XGBoost (F30 = 26.84%, MdPE = −5.88%) outperformed PopPK (F30 = 23.63%, MdPE = −13.88%). In single‐point sparse posterior prediction, PopPK (F30 = 29.71%, MdPE = 2.32%) performed best, while several ensembles improved over their neural network components. Overall, BiLSTM showed strong performance in dense data, XGBoost performed best in the prior sparse scenarios, and PopPK retained the advantage after prior concentration information was incorporated. ML approaches achieved similar accuracy to PopPK with unique advantages, representing promising tools for drug concentration prediction.
- Top Cited Papers
- 3 February 2025
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 117 (5) , 1236-1247
Machine Learning for Prediction of Drug Concentrations: Application and Challenges
With the advancements in algorithms and increased accessibility of multi‐source data, machine learning in pharmacokinetics is gaining interest. This review summarizes studies on machine learning‐based pharmacokinetics analysis up to September 2024, identified from the PubMed and IEEE Xplore databases. The main focus of this review is on the use of machine learning in predicting drug concentration. This review provides a comprehensive summary of the advances in the machine learning algorithms for pharmacokinetics analysis. Specifically, we describe the common practices in data preprocessing, the application scenarios of various algorithms, and the critical challenges that require attention. Most machine learning models show comparable performance to those of population pharmacokinetics models. Tree‐based algorithms and neural networks have the most applications. Furthermore, the use of ensemble modeling techniques can improve the accuracy of these models' predictions of drug concentrations, especially the ensembles of machine learning and pharmacometrics.
- 3 February 2025
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 117 (5) , 1236-1247
Top Cited PapersMachine Learning for Prediction of Drug Concentrations: Application and Challenges
With the advancements in algorithms and increased accessibility of multi‐source data, machine learning in pharmacokinetics is gaining interest. This review summarizes studies on machine learning‐based pharmacokinetics analysis up to September 2024, identified from the PubMed and IEEE Xplore databases. The main focus of this review is on the use of machine learning in predicting drug concentration. This review provides a comprehensive summary of the advances in the machine learning algorithms for pharmacokinetics analysis. Specifically, we describe the common practices in data preprocessing, the application scenarios of various algorithms, and the critical challenges that require attention. Most machine learning models show comparable performance to those of population pharmacokinetics models. Tree‐based algorithms and neural networks have the most applications. Furthermore, the use of ensemble modeling techniques can improve the accuracy of these models' predictions of drug concentrations, especially the ensembles of machine learning and pharmacometrics.